Comparison between Injecto Polymers IPO and M R Maniveni IPO.
Injecto Polymers IPO is a SME Bookbuilding IPO proposed to list at BSE SME while M R Maniveni IPO is a SME Bookbuilding proposed to list at BSE SME.
The total issue size of Injecto Polymers IPO is up to ₹0.00 Cr whereas the issue size of the M R Maniveni IPO is up to ₹0.00 Cr. The final issue price of Injecto Polymers IPO is and of M R Maniveni IPO is .
| Injecto Polymers IPO | M R Maniveni IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 56,13,500 shares | 65,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 56,13,500 shares | 65,00,000 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
Injecto Polymers IPO opens on , while M R Maniveni IPO opens on . The closing date of Injecto Polymers IPO and M R Maniveni IPO is , and , respectively.
Injecto Polymers IPO P/E ratio is , as compared to M R Maniveni IPO P/E ratio of .
| Injecto Polymers IPO | M R Maniveni IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Injecto Polymers Ltd.'s revenue increased by 138% and profit after tax (PAT) rose by 82% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated)M R Maniveni Foods Ltd.'s revenue increased by 31% and profit after tax (PAT) rose by 76% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 88.14 | 98.68 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 23.66 | 25.27 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 13.91 | 18.63 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 2.14 | 1.12 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 17.13 | 25.27 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Injecto Polymers IPO Retail Individual Investors (RII) are offered 0 shares while in M R Maniveni IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Injecto Polymers IPO and 0 shares in M R Maniveni IPO.
| Injecto Polymers IPO | M R Maniveni IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 0 shares | 0 shares |
| NII | 0 shares | 0 shares |
| RII | 0 shares | 0 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 0 shares |
Injecto Polymers IPO subscribed in total, whereas M R Maniveni IPO subscribed .
